Silver (XAG) Daily Forecast: Industrial Demand and Fed Expectations Drive Prices Toward $32Fri, 18 Oct 2024 06:56:35 GMT Gold (XAU) Daily Forecast: Uptrend Continues as Investors Eye Fed’s Next ...
View Tarsus Pharmaceuticals, Inc. (TARS) current and estimated P/E ratio data provided by Seeking Alpha.
Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...
TARS Project Management has shifted its focus to India’s pre-IPO market, aiming to tap into the country's private sector opportunities. The firm has received support from ADIB, a leading ...
Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of $60.00. The company’s shares closed last Friday at $39.41.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback